FDA Adverse Event Injury Summary report: N

OVITEX REINFORCED TISSUE MATRIX

MDR report key: 18798391 · Received February 28, 2024

Report

Report Number
3010513348-2024-00005
Event Type
Injury
Date Received
February 28, 2024
Date of Event
February 13, 2024
Report Date
February 28, 2024
Manufacturer
AROA BIOSURGERY
Product Code
FTM
Adverse Event
Yes
Report Source
Distributor report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

PLEASE NOTE THAT DATE OF IMPLANT IS APPROXIMATE TO THE MONTH OF IMPLANT REPORTED BY THE PHYSICIAN. IT CANNOT BE DETERMINED WHETHER THE DEVICE CAUSED OR CONTRIBUTED TO THE EVENT NOTED. SEROMA, INFECTION, AND REOPERATION ARE KNOWN ADVERSE EVENTS AND POTENTIAL OUTCOMES ASSOCIATED WITH HERNIA REPAIR SURGERY.

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT WHO UNDERWENT IPOM REPAIR WITH OVITEX 2S IN APPROXIMATELY (B)(6) 2023 RETURNED IN (B)(6) 2023 WITH A SEROMA. THIS WAS DRAINED UNDER IR A DRAIN PLACED IN (B)(6) 2023 WITH THE DRAIN REMOVED 3 WEEKS LATER. ON (B)(6) 2024 IT WAS REPORTED THAT THE SEROMA CONTINUED AND APPEARED TO HAVE BECOME INFECTED AND THE DEVICE WAS TO BE EXPLANTED THAT DAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
497855 OVITEX REINFORCED TISSUE MATRIX SURGICAL MESH FTM AROA BIOSURGERY

Patients

Seq Age Sex Outcome Treatment
1 49 YR Female Hospitalization| R